From Diagnosis to Dreamliners
DENVER, Colo., Sep 26, 2025 (247marketnews.com)- Today’s session includes a medley of powerful stories spanning from center stage to Stage 1.
bioAffinity Technologies (NASDAQ:BIAF) surged in pre-market trading following the release of three new real-world case studies demonstrating the clinical impact of its noninvasive diagnostic test CyPath Lung.
The test, which analyzes sputum using flow cytometry and AI, continues to show clinical promise. In one case, a hesitant patient diagnosed with Stage 1A lung cancer moved forward with biopsy only after a positive CyPath result. Two other cases showcased how negative results helped avoid unnecessary biopsies, providing a valuable decision-making tool in uncertain clinical situations.
“We believe CyPath Lung can be a transformative tool in the lung cancer diagnostic pathway,” said Chief Medical Officer Dr. Gordon Downie.
The announcement adds to growing momentum behind BIAF’s goal to reshape early lung cancer detection and reduce invasive procedures, especially valuable in high-risk but asymptomatic patients.
Venu Holdings (NYSE:VENU) is composing a symphony of economic growth, unveiling projections that its expanding portfolio of amphitheaters will generate over $17.7 billion in economic impact across McKinney, El Paso, and Broken Arrow over the next 20 years.
The big picture: VENU plans to build 40 venues by 2030, including 25 amphitheaters and 15 indoor complexes, aiming for 20 million tickets sold annually and over $2 billion in yearly ticket sales, in 2 years.
“We are on pace to add more than $5 billion in completed project value in the next 36 to 48 months,” said Founder and CEO J.W. Roth.
Backed by high-profile partnerships with Tixr, AEG Presents, Aramark, and NFL Hall of Famer Troy Aikman, the company is gaining Wall Street momentum. Cenorium Capital initiated coverage with a Strong Buy and $22 price target, while Northland Securities raised its target to $17.
Boeing Co. (NYSE:BA) is flying high after announcing major orders from two international carriers:
- Norwegian Group placed a new order for 30 Boeing 737-8 MAX jets.
- Turkish Airlines committed to up to 75 Boeing 787 Dreamliners and signaled a massive expansion of its 737 MAX fleet with a commitment to purchase up to 150 jets.
These deals come amid growing global airline recovery and fleet renewals, reaffirming confidence in Boeing’s aircraft lineup, especially as fuel efficiency becomes a leading metric for fleet buyers.
Spotlight Movers & Developments
Aqua Metals (NASDAQ:AQMS) remains in focus as a green-tech recycling innovator. Investors continue to watch for updates on its lithium-ion battery recycling pilot programs and potential licensing deals.
Eyes remain on Perpetua Resources (NASDAQ:PPTA) as analysts digest its ongoing progress with the Stibnite Gold Project, a key source of antimony, a critical mineral for defense and energy technologies. With bipartisan support for domestic sourcing, Perpetua could benefit from favorable regulatory tailwinds.
Investors are watching Crinetics Pharmaceuticals (NASDAQ:CRNX) closely following its recent Phase 3 topline data on paltusotine, a treatment for acromegaly. The stock has been range-bound pending FDA submission timelines but remains a mid-cap biotech to watch for 2026 catalysts.
Optics specialist LightPath Technologies (NASDAQ:LPTH) continues building its position in infrared sensing and defense. With geopolitical tensions rising and increased demand for thermal imaging, LPTH could see revenue upside in upcoming quarters.
With its U.S.-based semiconductor foundry model, SkyWater Technology (NASDAQ:SKYT) remains a strategic domestic chipmaker in the spotlight amid CHIPS Act implementation. Investors are on the lookout for new government or defense contracts as the company ramps up advanced packaging capabilities.
About Venu Holding Corporation
Venu Holding Corporation (NYSEAmerican:VENU) is redefining the live entertainment landscape through a national network of premium amphitheaters powered by its Luxe FireSuites model. With partnerships like AEG and Aramark, and an active development pipeline of over $5 billion (including $1 billion underway), Venu is building the next generation of destination venues, where investors, fans, and artists come together in a hospitality-first experience.
Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.
For the full 24/7 Market News VENU report and in-depth insights, visit: Read 24/7 Market News VENU Report/
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
CONTACT:
24/7 Market News
Editor@247marketnews.com